Herpes Zoster Knowledge, Prevalence, and Vaccination Rate by Race

References

1. 1.↵
   1. Arvin AM

   . Varicella-zoster virus. Clin Microbiol Rev 1996;9:361–81.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Oxman MN,
   2. Levin MJ,
   3. Johnson GR,
   4. et al

   . A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271–84.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Jumaan AO,
   2. Yu O,
   3. Jackson LA,
   4. et al

   . Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992–2002. J Infect Dis 2005;191:2002–7.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Insinga RP,
   2. Itzler RF,
   3. Pellissier JM,
   4. et al

   . The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005;20:748–53.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Schmader K,
   2. George LK,
   3. Burchett BM,
   4. et al

   . Racial differences in the occurrence of herpes zoster. J Infect Dis 1995;171:701–4.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Chaves SS,
   2. Santibanez TA,
   3. Gargiullo P,
   4. et al

   . Chickenpox exposure and herpes zoster disease incidence in older adults in the U.S. Public Health Rep 2007;122:155–9.

   OpenUrlPubMedWeb of Science
7. 7.↵
   1. Schmader K,
   2. George LK,
   3. Burchett BM,
   4. et al

   . Race and stress in the incidence of herpes zoster in older adults. J Am Geriatr Soc 1998;46:973–7.

   OpenUrlPubMedWeb of Science
8. 8.↵
   1. Katz J,
   2. Cooper EM,
   3. Walther RR,
   4. et al

   . Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 2004;39:342–8.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Yawn BP,
   2. Saddier P,
   3. Wollan PC,
   4. et al

   . A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007;82:1341–9.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Harpaz R,
    2. Ortega-Sanchez IR,
    3. Seward JF

    ; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008;57:1–30; quiz CE32–34.

    OpenUrlPubMed
11. 11.↵
    1. Sun W

    . US Food and Drug Administration. Approval letter - Zostavax [letter online]. March 24, 2011. Available at: www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm248608.htm. Accessed September 12, 2011.
12. 12.↵
    1. Hensley S

    , NPR. FDA gives OK to broader use of shingles vaccine [article online]. Available at: www.npr.org/blogs/health/2011/03/25/134849776/zostavax-fda-gives-ok-to-broader-use-of-shingles-vaccine. Accessed September 12, 2011.
13. 13.↵
    1. Lu PJ,
    2. Euler GL,
    3. Jumaan AO,
    4. et al

    . Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine 2009;27:882–7.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Wolf F,
    2. Michaud K

    . Rates and predictors of influenza, pneumococcal, and herpes zoster vaccination in adult patients with rheumatic diseases. Presented at the ACR/AHRP Scientific Meeting, October 17–21, 2009, Philadelphia, PA. Available at: http://acr.confex.com/acr/2009/webprogram/Paper10757.html. Accessed March 1, 2012.
15. 15.↵
    1. Hurley LP,
    2. Lindley MC,
    3. Harpaz R,
    4. et al

    . Barriers to the use of herpes zoster vaccine. Ann Intern Med 2010;152:555–60.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    Herpes zoster vaccine (Zostavax). Med Lett Drugs Ther 2006;48:73–4.

    OpenUrlPubMed
17. 17.↵
    1. Tseng H,
    2. Smith N,
    3. Harpez R

    . Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA 2011;305:160–16.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Simberkoff M,
    2. Arbeit R,
    3. Johnson G

    . Safety of Herpes Zoster Vaccine in the Shingles Prevention Study: a randomized trial. Ann Intern Med 2010;152:545–54.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    The Harvard Medical School Family Health Guide. The shingles vaccine: why hasn't it caught on? 2007. Available at: www.health.harvard.edu/fhg/updates/The-shingles-vaccine.shtml. Accessed September 12, 2011.
20. 20.↵
    Zostavax: full prescribing information. June 2011. Whitehouse Station, NJ: Merck & Co, Inc. Available at: www.merck.com/product/usa/pi_circulars/z/zostavax/zostavax_pi2.pdf. Accessed September 12, 2011.
21. 21.↵
    1. Schmader K,
    2. George LK,
    3. Newton R,
    4. et al

    . The accuracy of self-report of herpes zoster. J Clin Epidemiol 1994;47:1271–6.

    OpenUrlCrossRefPubMedWeb of Science